Interview: Carl Firth, CEO, ASLAN Pharmaceuticals, Taiwan
The CEO of ASLAN Pharmaceuticals discusses the fundamental changes that need to occur in the treatment of serious illnesses, the advantages of building a second branch in Taiwan, and the…
ASLAN is an Asia enabled pharmaceutical company that develops novel medicines for global markets.
1. ASLAN inlicenses preclinical drugs that are up to 6-12 months from the clinic
2. ASLAN uses its own financial resources and high quality CRO facilities to perform preclinical, Phase 1 and 2 studies on the partnered compounds
3. ASLAN gets Proof of Concept (PoC) for the partnered compounds in Asia
4. ASLAN outlicenses PoC compounds back to partner for global development and launch
Walsin Xinyi Building, 11/F
No. 1, Songzhi Road
Taipei 11047, Taiwan 11047
Tel: +886 2 8729 2180
Fax: +886 2 8729 2333
http://www.aslanpharma.com/index.html
The CEO of ASLAN Pharmaceuticals discusses the fundamental changes that need to occur in the treatment of serious illnesses, the advantages of building a second branch in Taiwan, and the…
Francis Hong, chairman of Taiwan Medical and Biotech Industry Association (TMBIA), takes a moment during the 2019 Medical Taiwan and Taiwan Medical Components & Manufacturing Expo (MCMEX) in Taipei to share…
Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned provider to a healthcare partner. Wu goes on to offer…
Today Su, CEO of Golden Biotechnology, introduces the innovative biotech developing a revolutionary botanical drug derived from the Taiwanese fungus Antrodia Camphorata. The company’s drug, Hocena®, has already received several…
Barry Lam, founder and chairman of Quanta Computer, shares the story of how he built the company into one of the world’s leading electronics and IT manufacturers. Lam then sheds…
With the USA and China locked in a trade war, China’s near neighbour Taiwan – with its strong scientific and technology base, political security and economic reliability – may stand…
Professor Shih-Hua Lin, president of Taiwan’s National Defense Medical Center, shares an overview of the academic and research environment of the institute as well as its role in cultivating the…
Scott Li, deputy director of H Spectrum, a biotech and talent incubator within the Foxconn group, explains the organization’s history and unique role in supporting Foxconn’s transition into healthcare. Li…
William Foreman, president of AmCham Taipei, describes the attractiveness and challenges of Taiwan’s business landscape and the implications of US-China relations on the island. Foreman goes on to highlight the…
Leo Liu, president of GeneReach Biotechnology Corp, shares the story of the diagnostics startup and explains his strategy to transition the company from a leading animal health point-of-care device manufacturer…
Susan Hsu, managing director of Taiwanese data-driven CRO StatPlus, speaks about the key trends impacting Taiwan’s clinical trial environment and goes on to share her views on the increasing attractiveness…
Tony Chung, CEO of Instant NanoBiosensors explains the potential of their fibre-optic biosensor technology – FOPPR, and the commercialization strategy for their light-sensing biomarker analyzer INB-D200. He also highlights Taiwan’s…
Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory and maturation trends in the region and shares his…
See our Cookie Privacy Policy Here